The size of the Single-use Bioprocessing Market in LATAM was worth USD 0.32 Billion in 2022. It is estimated to be growing at a CAGR of 17.2% and worth USD 0.70 Billion by 2027.
Single-use bioprocessing technology is a popularly used technique for the manufacturing of biopharmaceuticals. It is applied during the whole procedure of biopharmaceutical production, that is, from buffer and media preparation to shipping of biologics. Single-use bioprocessing procedures involve using different products like manifold assemblies, bioprocess containers and bags, single-use bioreactors, and single-use mixers. They cut the cost of complex bioproduction processes, such as cleaning, sterilization, and care of the big bioreactors.
The developing economy, increasing demand for disposable biopharmaceuticals, and increased spending ability are propelling the growth of the Latin American single-use bioprocessing systems market.
However, insufficient government support, leachability problems, and environmental and economic hazards are the main challenges faced by the single-use bioprocessing market. The market is showing huge potential in the future years and is expected to continue its growth.
This research report segmented and sub-segmented the Latin American Single-use Bioprocessing Market into the following categories:
Companies that are dominating the Latin American Single-use Bioprocessing Market profiled in this report are Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org